Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
GlobeNewswire
*Patient screening and enrollment initiated for the Phase II part of the international randomized Phase I/II trial with an overall..